Literature DB >> 11327101

The pleiotropic functions of peroxisome proliferator-activated receptor gamma.

M B Debril1, J P Renaud, L Fajas, J Auwerx.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors, initially described as molecular targets for synthetic compounds that induce peroxisome proliferation. PPARgamma is the best characterized of the PPARs. The heterodimer of PPARgamma with the retinoid X receptor (RXR) plays a crucial role in adipogenesis and insulin sensitization. The RXR/PPARgamma heterodimer furthermore has been reported to have important immunomodulatory activities and to affect cell proliferation/differentiation pathways in various malignancies. PPARgamma is activated by a number of naturally occurring fatty acid derivatives and by several synthetic compounds, including the thiazolidinediones and L-tyrosine-based insulin sensitizers. This review gives an overview of the pleiotropic functions of PPARgamma and discusses the wide-ranging medical implications that modulation of PPARgamma activity might have for various diseases, ranging from obesity and type 2 diabetes to cancer and inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11327101     DOI: 10.1007/s001090000145

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  51 in total

Review 1.  COX-2 and cancer: a new approach to an old problem.

Authors:  Y S Bakhle
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

2.  Peroxisome proliferator-activated receptor-γ is downregulated in ulcerative colitis and is involved in experimental colitis-associated neoplasia.

Authors:  Xiaotan Dou; Junhua Xiao; Ziliang Jin; Ping Zheng
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

Review 3.  Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations.

Authors:  Jochen Maul; Martin Zeitz
Journal:  Langenbecks Arch Surg       Date:  2011-04-09       Impact factor: 3.445

Review 4.  The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity.

Authors:  Francesco S Celi; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

Review 5.  Genetics of insulin resistance.

Authors:  Maria M Mercado; John C McLenithan; Kristi D Silver; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-02       Impact factor: 4.810

6.  Ligands for PPARgamma and RAR cause induction of growth inhibition and apoptosis in human glioblastomas.

Authors:  Chuanbing Zang; Marlies Wächter; Hongyu Liu; Maximilian G Posch; Martin H Fenner; Christine Stadelmann; Andreas von Deimling; Kurt Possinger; Keith L Black; H Phillip Koeffler; Elena Elstner
Journal:  J Neurooncol       Date:  2003-11       Impact factor: 4.130

7.  Expression and initial promoter characterization of PCAN1 in retinal tissue and prostate cell lines.

Authors:  D Cross; D J Reding; S A Salzman; K Q Zhang; W J Catalona; J Burke; J K Burmester
Journal:  Med Oncol       Date:  2004       Impact factor: 3.064

8.  miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130.

Authors:  Qiang Wang; Yan Chun Li; Jinhua Wang; Juan Kong; Yuchen Qi; Richard J Quigg; Xinmin Li
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

9.  Role of PPARs in Radiation-Induced Brain Injury.

Authors:  Sriram Ramanan; Weiling Zhao; David R Riddle; Mike E Robbins
Journal:  PPAR Res       Date:  2009-09-17       Impact factor: 4.964

10.  Initiation of the expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in the rat ovary and the role of FSH.

Authors:  Mary J Long; M Ram Sairam; Carolyn M Komar
Journal:  Reprod Biol Endocrinol       Date:  2009-12-07       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.